Surfactant protein A as an important biomarker for interstitial lung disease in the assessment of occurrence, progression, acute exacerbation, and mortality: A systematic review and meta-analysis
Elevated serum SP-A emerges as a pivotal noninvasive biomarker for assessing disease states and prognosis in ILD patients.
Authors
- Dan Zheng (ORCID: https://orcid.org/0009-0007-6377-8177)
- Linjie Luo (ORCID: https://orcid.org/0000-0001-6322-1175)
- Xing He
- Lu Guo (ORCID: https://orcid.org/0009-0000-2274-0809)
- Jiaqi Ji (ORCID: https://orcid.org/0000-0002-2190-9040)
- Zeli Luo
Institutions
- University of Electronic Science and Technology of China (CN)
- Sichuan University (CN)
- Wuqing District People's Hospital (CN)
- West China Hospital of Sichuan University (CN)
- Luye Pharma (China) (CN)
- S.P.E.C.I.E.S. (US)
Publication Details
- Journal
- Medicine
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1097/md.0000000000045616
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00